
Sign up to save your podcasts
Or


Based on Podcast App listening data
Shinshu University (Japan), February 26, 2021
Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many physiological activities, which include anti-oxidation, anti-inflammatory, anti-cancer, and anti-amyloid properties. However, the mechanism and network of action are not completely clear. Amyloidosis is a group of diseases characterized by abnormal aggregates of proteins, known as amyloid fibrils, and subsequent deposition in various tissues and organs, such as Alzheimer's disease, immunoglobulin light chain amyloidosis.
In previous studies, curcumin has been shown to suppress the aggregation and cytotoxicity of many amyloid proteins in vitro, such as amyloid ß (Aß), α-synuclein, transthyretin, and prion protein, and has also been reported to inhibit the deposition of Aß fibrils in a mouse model of Alzheimer's disease. The group investigated amyloid deposition and molecular changes in a mouse model of amyloid apolipoprotein A-II (AApoAII) amyloidosis, in which mice were fed a curcumin-supplemented diet. In this research, it was found that curcumin intake elevated ApoA-II and HDL-cholesterol concentration in plasma by activating the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway, resulting in increased AApoAII amyloid deposition and peroxisome proliferation. These findings demonstrate the novel agonistic effect of curcumin on PPARα, which is an important transcription factor for lipid metabolism, and may have far-reaching significance for the treatment of amyloidosis and other metabolic disorders.
It was reported that high-fat diet supplement aggravates a variety of amyloid deposition including Aß in Alzheimer's disease model mice, but a link between lipid metabolism and the development of amyloidosis has not been completely established. These results provide a promising molecular target to understand the molecular mechanism of amyloidogenesis, which the activation state of PPARα pathway may be a bridge to connect the change of lipid metabolism level and the degree of amyloid deposition. In addition, it has been regarded that curcumin, as an agonist of PPARγ, exerts anti-inflammatory, anti-cancer and antioxidant activities in the past. However, this study demonstrates that curcumin is a PPARα/γ dual activator and may affect expression levels of proteins involved in amyloid deposition and other metabolism functions in a complex manner. By focusing on the PPARα pathway, the group hope to provide an opportunity to reconsider the mechanism of the physiological effects of curcumin.
In the next stage, the group would like to clarify how curcumin activates the PPARα signaling pathway in vitro and confirm whether the activation of PPARα can affect amyloid deposition on other types of amyloidosis in vivo (Alzheimer's disease, ATTR amyloidosis etc.). The goal in this research is to elucidate the molecular pathways involved in the pathogenesis of amyloidosis in vivo and to develop effective therapeutic or preventive methods against the development of amyloidosis. As a future study, the group hopes to fully understand the molecular fluctuations of PPARα-activated cells and verify the effectiveness of interventions in these pathways for various metabolic diseases.
University of Iowa, February 24, 2021
Postmenopausal women who ate high levels of plant protein had lower risks of premature death, cardiovascular disease and dementia-related death compared with women who ate less plant proteins, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Previous research has shown an association between diets high in red meat and cardiovascular disease risk, yet the data is sparse and inconclusive about specific types of proteins, the study authors say.
In this study, researchers analyzed data from more than 100,000 postmenopausal women (ages 50 to 79) who participated in the national Women's Health Initiative study between 1993 and 1998; they were followed through February 2017. At the time they enrolled in the study, participants completed questionnaires about their diet detailing how often they ate eggs, dairy, poultry, red meat, fish/shellfish and plant proteins such as tofu, nuts, beans and peas. During the study period, a total of 25,976 deaths occurred (6,993 deaths from cardiovascular disease; 7,516 deaths from cancer; and 2,734 deaths from dementia).
Researchers noted the levels and types of protein women reported consuming, divided them into groups to compare who ate the least and who ate the most of each protein. The median percent intake of total energy from animal protein in this population was 7.5% in the lowest quintile and 16.0% in the highest quintile. The median percent intake of total energy from plant protein in this population was 3.5% in the lowest quintile and 6.8% in the highest quintile.
Among the key findings:
"It is unclear in our study why eggs were associated with a higher risk of cardiovascular and cancer death," said lead study author Wei Bao, M.D., Ph.D., an assistant professor of epidemiology at the University of Iowa in Iowa City. "It might be related to the way people cook and eat eggs. Eggs can be boiled, scrambled, poached, baked, basted, fried, shirred, coddled or pickled or in combinations with other foods. In the United States, people usually eat eggs in the form of fried eggs and often with other foods such as bacon. Although we have carefully accounted for many potential confounding factors in the analysis, it is still difficult to completely tease out whether eggs, other foods usually consumed with eggs, or even non-dietary factors related to egg consumption, may lead to the increased risk of cardiovascular and cancer death."
Researchers noted that substitution of total red meat, eggs or dairy products with nuts was associated with a 12% to 47% lower risk of death from all causes depending on the type of protein replaced with nuts.
"It is important to note that dietary proteins are not consumed in isolation, so the interpretation of these findings could be challenging and should be based on consideration of the overall diet including different cooking methods," said Yangbo Sun, M.D., Ph.D., co-author of the study, a postdoctoral research scholar at the University of Iowa in Iowa City and currently an assistant professor of epidemiology at the University of Tennessee Health Science Center.
The analysis also revealed that women who ate the highest amount of animal protein such as meat and dairy were more likely to be white and have a higher education and income, and they were more likely to be past smokers, drink more alcohol and be less physically active. Moreover, these women were more likely to have Type 2 diabetes at the start of the study, a family history of heart attacks and a higher body mass index -- all risk factors for cardiovascular disease.
"Our findings support the need to consider dietary protein sources in future dietary guidelines," said Bao. "Current dietary guidelines mainly focus on the total amount of protein, and our findings show that there may be different health influences associated with different types of protein foods."
2020-2025 Dietary Guidelines for Americans, jointly published by the U.S. Departments of Agriculture (USDA) and Health and Human Services (HHS), recommend eating a variety of protein foods: low-fat meat, low-fat poultry, eggs, seafood, beans, peas, lentils, nuts, seeds and soy products including at least 8 ounces of cooked seafood per week.
The AHA's 2020 Dietary Cholesterol and Cardiovascular Risk advisory notes that given the relatively high content of cholesterol in egg yolks, it remains advisable to limit intake. Healthy individuals can include up to one whole egg or the equivalent daily.
The study had several limitations including that it was observational, based on self-reported data at the beginning of the study and lacked data on how the proteins were cooked. In addition, the findings may not apply to younger women or men.
Citrus Flavonoid May Help to Improve Metabolic and Inflammatory Markers
Sao Paulo State University (Brazil), February 20, 2021
The researchers from Sao Paulo State University and the US Horticultural Research Laboratory associated the citrus flavonoid with a significant reduction in levels of cholesterols and triglycerides which are markers of insulin resistance at low (10 and 25 mg/kg BW) and high ( 100 mg/kg BW) doses, with the best results being observed at 25 mg per kg of body weight.
The study authors wrote, “Therefore, our results showed that low doses of dietary eriocitrin are able to counteract the deleterious effects of high-fat diet and prevent risk factors of metabolic syndrome and chronic disease related to obesity.”
“Further, the use of lower doses may help to prevent unintended complications possibly occurring at much higher doses of potent antioxidant supplements such as eriocitrin.”
“As a leading supplier of citrus flavonoids, we put great importance into the continual development of research into these powerful ingredients,” said Rob Brewster who is the President of Ingredients by Nature (IBN). “Eriocitrin is not as commonly recognized as other fruit-derived flavonoids, but the science shows that it is a potent source of health support for a variety of health complications. We look forward to seeing what future research will continue to reveal about it.”
During this study 40 male mice were fed a high-fat diet for 4 weeks to induce obesity, then they were divided at random into four different groups for an additional 4 weeks and given doses of eriocitrin at 0, 10, 25, or 100 mg per kg of body weight, while a control group was fed a standard diet for the 8 weeks.
The researchers reported the best results being observed in the eriocitrin group taking 25 mg/kg with reductions in triglycerides of 31%, total cholesterol of 6%, and liver triacylglycerols of 28% compared to the control group. Eriocitrin at 25 mg/kg was associated with a reduction in lipid peroxidation of 19%, and markers of insulin resistance including resistin and the insulin resistance index also significantly decreased. Additionally, serum glucose levels also significantly decreased by 25%, insulin levels by 35% in this same group.
“Most studies on eriocitrin haven’t explored its effect on obesity induces metabolic disturbances and, because the global rate of obesity continues to increase, we felt that it was important to examine the topic further,” said the corresponding author Dr. Thais Cesar who is also an associate professor of nutrition at Sao Paulo State University. “Eriocitrin significantly improved metabolic, inflammatory, and oxidative stress parameters across multiple biomarkers, showing potential to delay the development of inflammatory complications. We look forward to performing additional research on eriocitrin in the future.”
This study was sponsored by IBM, and also showed that eriocitrin was effective in terms of glucose and lipid metabolism, especially with blood glucose reduction, along with delivering a strong antioxidant defense by directly helping the uptake of oxygen radicals and promoting the activation of endogenous defense mechanisms. This effect has been reported in previous studies including with the lemon flavonoid blend Eriomin, which is made up primarily of eriocitrin. Last year, the company also received patent approval from the USPTO for IBN’s use of eriocitrin as a method of reducing blood glucose levels
Resveratrol may be an effective intervention for lung aging
The Saban Research Institute (Los Angeles), February 22, 2021
In a study led by Barbara Driscoll, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, researchers demonstrate, for the first time that inhaled resveratrol treatments slow aging-related degenerative changes in mouse lung. Lung aging, characterized by airspace enlargement and decreasing lung function, is a significant risk factor for chronic human lung diseases. The study is published online in the journal Thorax.
"We believe that ours is the first study to demonstrate a beneficial effect of lung-directed resveratrol treatments on aging lung function," said Driscoll.
Resveratrol (RSL), a chemical found in red wine, is an antimicrobial chemical substance produced by plants to protect against infection and stress-related changes. It has previously been shown to support muscle metabolism when delivered orally.
RSL prophylaxis by inhalation was a novel measure taken by the research team as a potential approach for slowing age-related deterioration of lung function and structure by preserving alveolar epithelial type 2 cells (AEC2) which line alveoli (the tiny air sacs in the lungs through which the exchange of oxygen and carbon dioxide takes place) and produce surfactant which is vital for efficient breathing.
In healthy young adults, breathing is an essential, efficient process, but natural aging of the lung occurs at a steady and irreversible rate, as measured by a decline in lung function. This natural deterioration leads to a significantly reduced quality of life, over a time frame dependent on genetic and environmental factors. Although some available therapies can ameliorate symptoms, aging-related lung failure is generally irreversible and is accompanied by high rates of morbidity and mortality due to increased disease risk, including development of COPD, with accompanying emphysema and chronic bronchitis.
Using a rapidly aging mouse model, the research team investigated whether the accumulation of age-related degenerative changes in the lung could be slowed by inhaled RSL. Treatment cohorts received either RSL or vehicle by intratracheal (IT) instillation monthly for three months. One month following the final treatment, whole lung function and injury-related gene expression in AEC2 were assessed.
The research team found that inhaled, prophylactic resveratrol treatments can slow the rate of lung function decline, alveolar enlargement and alveolar epithelial type 2 cell DNA damage that occurs in the early stages of lung aging. They concluded that administration of resveratrol directly to the lungs may be an effective intervention for lung aging, which is a significant risk factor for development of chronic lung disease.
"While the natural deterioration of the human lung generally occurs over decades, the injury to lung cells is analogous to the lung cell damage that occurs in premature infants who experience respiratory distress before their lungs have fully developed," added Driscoll. "Identifying a way to protect and strengthen young lungs before significant damage occurs is the goal of our research."
Kathmandu Medical College (Nepal), February 19, 2021
According to news reporting out of Kathmandu Medical College research stated, “Magnesium deficiency is common in the elderly and critically ill population and has been associated with a prolonged ICU stay. The knowledge of hypomagnesemia is essential as it could have prognostic and therapeutic implications in the elderly population.”
The news correspondents obtained a quote from the research from Kathmandu Medical College: “This study aimed to estimate the prevalence of hypomagnesemic in the elderly population visiting a tertiary care center. This descriptive cross-sectional study was conducted in a tertiary care hospital from March 21, 2020 to September 21, 2020. After obtaining ethical clearance from the institutional review committee (Ref. 2003202008), convenience sampling was done. Data were collected and entered in Microsoft Excel version 2007. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data. Out of 384 participants, 174 (45%) participants were found to have deranged magnesium levels, in which 111 (29%) (31.3-26.7 at 95% Confidence Interval) were found to be hypomagnesemia. Among them, 62 (29.4%) males and 49 (28.5%) females were hypomagnesemia. The average level of serum magnesium was 2.02±0.76 mg/dl ranging from 0.03 to 4.71. The mean age of participants was 70.31±8.13 years, among which the participants between the age group of 71-80 years presented with a maximum percentage of hypomagnesemia.”
According to the news reporters, the research concluded: “The present study has shown that an apparently-healthy elderly population may have a magnesium deficiency that may need to be identified and treated for optimizing clinical care. Further multicentric studies with a greater sample size should be done in this field, which will benefit the elderly population.”
University of Texas Medical Center, February 24, 2021
Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have identified the specialized environment, known as a niche, in the bone marrow where new bone and immune cells are produced. The study, published in Nature, also shows that movement-induced stimulation is required for the maintenance of this niche, as well as the bone and immune-forming cells that it contains. Together, these findings identify a new way that exercise strengthens bones and immune function.
Researchers from the Morrison laboratorydiscovered that forces created from walking or running are transmitted from bone surfaces along arteriolar blood vessels into the marrow inside bones. Bone-forming cells that line the outside of the arterioles sense these forces and are induced to proliferate. This not only allows the formation of new bone cells, which helps to thicken bones, but the bone-forming cells also secrete a growth factor that increases the frequency of cells that form lymphocytes around the arterioles. Lymphocytes are the B and T cells that allow the immune system to fight infections.
When the ability of the bone-forming cells to sense pressure caused by movement, also known as mechanical forces, was inactivated, it reduced the formation of new bone cells and lymphocytes, causing bones to become thinner and reducing the ability of mice to clear a bacterial infection.
"As we age, the environment in our bone marrow changes and the cells responsible for maintaining skeletal bone mass and immune function become depleted. We know very little about how this environment changes or why these cells decrease with age," says Sean Morrison, Ph.D., the director of CRI and a Howard Hughes Medical Institute Investigator. "Past research has shown exercise can improve bone strength and immune function, and our study discovered a new mechanism by which this occurs."
Previous work from the Morrison laboratory discovered the skeletal stem cells that give rise to most of the new bone cells that form during adulthood in the bone marrow. They are Leptin Receptor+ (LepR+) cells. They line the outside of blood vessels in the bone marrow and form critical growth factors for the maintenance of blood-forming cells. The Morrison lab also found that a subset of LepR+ cells synthesize a previously undiscovered bone-forming growth factor called Osteolectin. Osteolectin promotes the maintenance of the adult skeleton by causing LepR+ to form new bone cells.
In the current study, Bo Shen, Ph.D., a postdoctoral fellow in the Morrison laboratory, looked more carefully at the subset of LepR+ cells that make Osteolectin. He discovered that these cells reside exclusively around arteriolar blood vessels in the bone marrow and that they maintain nearby lymphoid progenitors by synthesizing stem cell factor (SCF) - a growth factor on which those cells depend. Deleting SCF from Osteolectin-positive cells depleted lymphoid progenitors and undermined the ability of mice to mount an immune response to bacterial infection.
"Together with our previous work, the findings in this study show Osteolectin-positive cells create a specialized niche for bone-forming and lymphoid progenitors around the arterioles. Therapeutic interventions that expand the number of Osteolectin-positive cells could increase bone formation and immune responses, particularly in the elderly," says Shen.
Shen found that the number of Osteolectin-positive cells and lymphoid progenitors decreased with age. Curious if he could reverse this trend, Shen put running wheels in the cages so that the mice could exercise. He found the bones of these mice became stronger with exercise, while the number of Osteolectin-positive cells and lymphoid progenitors around the arterioles increased. This was the first indication that mechanical stimulation regulates a niche in the bone marrow.
Shen found that Osteolectin-positive cells expressed a receptor on their surfaces - known as Piezo1 - that signals inside the cell in response to mechanical forces. When Piezo1 was deleted from Osteolectin-positive cells of mice, these cells and the lymphoid progenitors they support became depleted, weakening bones and impairing immune responses.
"We think we've found an important mechanism by which exercise promotes immunity and strengthens bones, on top of other mechanisms previously identified by others," says Morrison.
According to news reporting originating in Aalborg, Denmark, research stated, “Iodine intake affects the occurrence of thyroid disorders. However, the association of iodine intake with longevity remains to be described.”
The news reporters obtained a quote from the research from Aalborg University Hospital, “This led us to perform a 20 years’ follow-up on participants from the Randers-Skagen (RaSk) study. Residents in Randers born in 1920 (n 210) and Skagen born in 1918-1923 (n 218) were included in a clinical study in 1997-1998. Mean iodine content in drinking water was 2 mu g/l in Randers and 139 mu g/l in Skagen. We collected baseline data through questionnaires, performed physical examinations and measured iodine concentrations in spot urine samples. Income data were retrieved from Danish registries. We performed follow-up on mortality until 31 December 2017 using Danish registries. Complete follow-up data were available on 428 out of 430 of participants (99 center dot 5 %). At baseline, the median urinary iodine concentration was 55 mu g/l in Randers and 160 mu g/l in Skagen residents. Participants were long-term residents with 72.8 and 92.7 % residing for more than 25 years in Randers and Skagen, respectively. Cox regression showed that living in Skagen compared with Randers was associated with a lower hazard ratio (HR) of death in both age- and sex-adjusted analyses (HR 0.60, 95 % CI 0.41, 0.87, P = 0.006), but also after adjustment for age, sex, number of drugs, Charlson co-morbidity index, smoking, alcohol and income (HR 0.60, 95 % CI 0.41, 0.87, P = 0.008). Residing in iodine-replete Skagen was associated with increased longevity.”
According to the news reporters, the research concluded: “This indicates that long-term residency in an iodine-replete environment may be associated with increased longevity compared with residency in an iodine-deficient environment.”
This research has been peer-reviewed.
The results of human studies assessing the efficacy of lycopene on insulin-like growth factor 1 (IGF-1) levels are inconsistent. Thus, we performed a systematic review and meta-analysis to examine the effects of lycopene supplementation on serum IGF-1 levels and cardiovascular disease.
The literature published up to January 2020 was searched using the electronic databases Scopus, PubMed/Medline, Web of Science, Embase and Google Scholar.
Seven qualified trials were included in the current meta-analysis. IGF-1 levels were non-significantly decreased in lycopene group compared to the control (WMD: −6.74 ng/mL, 95 % CI: −23.01 to 9.52, p = 0.42; I2 = 94.3 %). Subgroup analysis revealed a significantly decrease in IGF-1 levels upon lycopene supplementation at doses ≥15 mg/d (WMD: −6.40 ng/mL), intervention period 15 mg/d, for
Tabriz University of Medical Sciences (Iran), February 24 2021.
A randomized trial reported on February 18, 2021 in Complementary Therapies in Medicine resulted in improvement of several factors related to type 2 diabetes among men and women who were given supplements containing French maritime pine bark extract.
The trial included 46 diabetics between the ages of 30 and 65 years who were recruited from March 2018 to April 2019. Participants received two capsules that provided 50 milligrams each of French maritime bark extract or a placebo daily for eight weeks. Diet and medication use remained unchanged throughout the trial. Anthropometric factors, glycemic parameters, lipids and factors related to inflammation and kidney function were assessed at the beginning and end of the study.
At eight weeks, waist circumference, waist to height ratio, hemoglobin A1c, total cholesterol, vascular cell adhesion molecule 1 (VCAM-1, an inflammatory cell that contributes to atherosclerosis), and urinary albumin to creatinine ratio (an early indicator of kidney disease) were lower at the end of the study among participants who received French maritime pine bark extract in comparison with the placebo. Serum fasting blood glucose levels were also lower at the end of the study in the group that received the extract; however, the reduction was not considered significant.
“There is a growing body of evidence that suggests pine bark extract supplementation has some potentially beneficial metabolic properties such as anti-diabetic and hypoglycemic effects,” Elham Navval-Esfahlan and colleagues wrote.
“The present study indicated that daily supplementation with 100 mg of pine bark extract in patients with type 2 diabetes mellitus and microalbuminuria had favorable effects on glycemic control, serum VCAM-1, and urinary albumin to creatine ratio level, as well as total cholesterol concentrations and abdominal obesity which could be helpful in the control of diabetes complications,” they concluded.
University of Manchester (UK), February 22 2021.
An epidemiologic study conducted at the University of Manchester found an association between zinc supplementation and a decreased risk of Alzheimer's disease as well as a reduction in the progression of cognitive decline in Alzheimer's disease patients. It was additionally determined that zinc deficiency accelerated memory deficits in an Alzheimer's disease mouse model compared to a control group, due to increased inflammation. The findings were reported in an article appearing on February 17, 2021 in the Journal of Neuroscience.
For the epidemiologic study, Jack Rivers-Auty and his associates utilized data from the Alzheimer’s Disease Neuroimaging Initiative database, which included 1,631 men and women who were cognitively normal or diagnosed with mild cognitive impairment or early Alzheimer's disease. Subjects were evaluated upon enrollment, at six and 12 months, and yearly thereafter. Data obtained at the beginning of the study provided information concerning the use of nutritional supplements.
Among those who reported supplementing with zinc, just 6% were diagnosed with Alzheimer's disease, in contrast with 26% of those who reported no supplement use. Calcium, iron and magnesium also appeared to be protective. Zinc use was additionally associated with a less rapid rate of cognitive decline during up to ten years of follow-up.
Giving mice zinc deficient diets was associated with increased cognitive decline due to enhanced NLRP3-driven inflammation, which was reversed by giving the animals diets that contained a normal amount of zinc. “These data suggest that zinc deficiency is causally accelerating cognitive decline in Alzheimer’s disease and that these cognitive deficits are reversible,” Dr Rivers-Auty and colleagues wrote.
“This research suggests that zinc status is linked to inflammatory reactivity and may be modified in people to reduce the risk and slow the progression of Alzheimer’s disease,” they concluded.
University of Massachusetts, February 22, 2021
According to news reporting from Lowell, Massachusetts, research stated, “There is evidence that low plasma vitamin B-12 and folate individually, as well as an imbalance of high folic acid and low vitamin B-12 status, may be associated with lower cognitive function. We examined dietary and plasma folate and vitamin B12 status, and their interaction, in relation to cognitive function in a cohort of older Puerto Rican adults.”
The news correspondents obtained a quote from the research from the University of Massachusetts Lowell, “The design is cross-sectional, with 1408 participants from the Boston Puerto Rican Health Study (mean SD age: 57.1 +/- 7.9 y). Cognitive function was assessed with a comprehensive test battery and a global composite score was derived. Plasma folate, vitamin B12, and methylmalonic acid (MMA) were assessed in fasting blood samples. After adjusting for covariates, high plasma folate and high plasma vitamin B-12 were each positively associated with global cognitive score (beta: 0.063; 95% CI: -0.0008, 0.127; P = 0.053 and beta: 0.062; 95% CI: 0.009, 0.12; P = 0.023, respectively, for logged values, and beta: 0.002; 95% CI: 0.00005, 0.004; P-trend = 0.044 and beta: 0.00018; 95% CI: 0.00001, 0.0003; P-trend = 0.036, respectively, across tertiles). Nine percent of participants had vitamin B-12 deficiency (plasma vitamin B-12 148 pmol/L or MMA 271 nmol/L), but none were folate deficient (plasma folate < 4.53 nmol/L). Deficient compared with higher vitamin B-12 was significantly associated with lower cognitive score (beta: -0.119; 95% CI: -0.208, -0.029; P = 0.009). We could not examine the interaction for vitamin B-12 deficiency and high plasma folate, because there were too few individuals (
Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.
Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.
Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.
Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.
Data from over 9,000 people reveal a distinct gut microbiome signature that is associated with healthy aging and survival in the latest decades of life
Institute for Systems Biology (Seattle), February 18, 2021
The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are associated with either healthy or unhealthy aging trajectories, which in turn predict survival in a population of older individuals. The work is set to be published in the journal Nature Metabolism.
The research team analyzed gut microbiome, phenotypic and clinical data from over 9,000 people - between the ages of 18 and 101 years old - across three independent cohorts. The team focused, in particular, on longitudinal data from a cohort of over 900 community-dwelling older individuals (78-98 years old), allowing them to track health and survival outcomes.
The data showed that gut microbiomes became increasingly unique (i.e. increasingly divergent from others) as individuals aged, starting in mid-to-late adulthood, which corresponded with a steady decline in the abundance of core bacterial genera (e.g. Bacteroides) that tend to be shared across humans.
Strikingly, while microbiomes became increasingly unique to each individual in healthy aging, the metabolic functions the microbiomes were carrying out shared common traits. This gut uniqueness signature was highly correlated with several microbially-derived metabolites in blood plasma, including one - tryptophan-derived indole - that has previously been shown to extend lifespan in mice. Blood levels of another metabolite - phenylacetylglutamine - showed the strongest association with uniqueness, and prior work has shown that this metabolite is indeed highly elevated in the blood of centenarians.
"This uniqueness signature can predict patient survival in the latest decades of life," said ISB Research Scientist Dr. Tomasz Wilmanski, who led the study. Healthy individuals around 80 years of age showed continued microbial drift toward a unique compositional state, but this drift was absent in less healthy individuals.
"Interestingly, this uniqueness pattern appears to start in mid-life - 40-50 years old - and is associated with a clear blood metabolomic signature, suggesting that these microbiome changes may not simply be diagnostic of healthy aging, but that they may also contribute directly to health as we age," Wilmanski said. For example, indoles are known to reduce inflammation in the gut, and chronic inflammation is thought to be a major driver in the progression of aging-related morbidities.
"Prior results in microbiome-aging research appear inconsistent, with some reports showing a decline in core gut genera in centenarian populations, while others show relative stability of the microbiome up until the onset of aging-related declines in health," said microbiome specialist Dr. Sean Gibbons, co-corresponding author of the paper. "Our work, which is the first to incorporate a detailed analysis of health and survival, may resolve these inconsistencies. Specifically, we show two distinct aging trajectories: 1) a decline in core microbes and an accompanying rise in uniqueness in healthier individuals, consistent with prior results in community-dwelling centenarians, and 2) the maintenance of core microbes in less healthy individuals."
This analysis highlights the fact that the adult gut microbiome continues to develop with advanced age in healthy individuals, but not in unhealthy ones, and that microbiome compositions associated with health in early-to-mid adulthood may not be compatible with health in late adulthood.
"This is exciting work that we think will have major clinical implications for monitoring and modifying gut microbiome health throughout a person's life," said ISB Professor Dr. Nathan Price, co-corresponding author of the paper.
University of Tokyo (Japan), February 15, 2021
According to news originating from the University of Tokyo , research stated, “Rosmarinic acid (RA), a polyphenol found in Lamiaceae herbs, is a candidate of preventive ingredients against Alzheimer’s disease (AD) as it potently suppresses the aggregation of amyloid b (Ab); however, the effect of RA on tau phosphorylation and cognitive dysfunction remains unclear.”
Financial supporters for this research include Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development; Cross-Ministerial Strategic Innovation Promotion Program.
The news editors obtained a quote from the research from University of Tokyo: “The present study revealed that RA intake inhibited the pathological hallmarks of AD, including Ab and phosphorylated tau accumulation, and improved cognitive function in the 3 x Tg-AD mouse model. Additionally, RA intake suppressed hippocampal inflammation and led to the downregulation of the JNK signaling pathway that induces tau phosphorylation. Feeding with RA exerted an anti-inflammatory effect not only in the central nervous system but also in the periphery.”
According to the news editors, the research concluded: “Downregulation of the JNK signaling pathway in hippocampus may be a potential mechanism underlying the inhibition of progression of pathology and cognitive deficit by RA feeding.”
University of Granada (Spain), February 15, 2021
Researchers from the University of Granada warn that an accumulation of fatty tissue in the neck (both the double chin and the deeper deposits, located between muscles and around the cervical vertebrae) is a predictor of central and overall adiposity, cardiometabolic risk, and a pro-inflammatory profile in sedentary young adults.
Traditionally, the accumulation of visceral adipose tissue has been considered one of the factors most strongly related to cardiometabolic risk and chronic (low-grade) inflammation in humans. However, this well-established association has led researchers to neglect, to some degree, the study of other fatty deposits and their clinical/biological relevance.
"Curiously, several studies have demonstrated that the accumulation of fat in the neck (both superficial deposits such as the double chin or jowls and the deeper deposits, located between the muscles and around the cervical vertebrae) increases in direct proportion to the weight or adiposity of the individual and that it follows specific accumulation patterns, according to gender," explains María José Arias Téllez, a researcher at the UGR and one of the main authors of this work.
In fact, a greater accumulation of fat in certain neck tissue compartments, particularly the deeper ones, is linked to a greater likelihood of cardiometabolic risk. Arias Téllez says, "However, the evidence accumulated to date has been based on experiments performed on patients with benign/malignant tumors or other chronic conditions, and it remains to be seen whether it can be generalized to relatively healthy adults."
The study carried out at the UGR is part of the ACTIBATE project (Activating Brown Adipose Tissue through Exercise—seeprofith.ugr.es/actibate). The research was led by Jonatan Ruiz Ruiz and its results have been published in the International Journal of Obesity.
The study shows that the accumulation of fat in the neck—measured with computed tomography scanning—as well as its distribution in different compartments, is associated with greater overall and central adiposity, greater cardiometabolic risk, and a greater inflammatory status among healthy young adults, regardless of the amount of total and visceral fat. In addition, among the most relevant findings, the researchers observed that this accumulation of fat in the neck was as powerful a factor (in terms of direction and magnitude) as the accumulation of visceral fat in the prediction of cardiometabolic risk and inflammatory status, especially in men.
"Therefore, these results underline the need for further research in this new direction, to better understand the effect of fat accumulation in the upper part of the trunk (including the neck) and its clinical repercussions, especially in cardiometabolic riskand inflammation," explains Francisco Miguel Acosta Manzano, one of the main authors of the research.
"We still have much work to do. We need to investigate the adipose tissue of the neck in greater depth, to understand its pathogenic role in obesity and associated comorbidities, as well as its biological importance. Furthermore, we only have scant knowledge about the morphological or molecular characteristics of the adipocytes in these deposits, and here basic studies are required. As we increase our knowledge of this deposit, we can also determine whether specific interventions (for example, physical exercise and/or restricted calorie intake) could help reduce the accumulation of fat in the neck (as well as total fat) and implement them clinically," explain Arias Téllez and Francisco Miguel Acosta Manzano, both Ph.D.s students on the Biomedicine program of the UGR's International School for Postgraduate Studies
According to news reporting originating from Newcastle upon Tyne, United Kingdom, research stated, “Anxiety, stress, and low mood are closely related and may contribute to depressive symptoms. Among non-pharmacological solutions to improve subclinical mood symptoms and resilience to stress, natural products such as saffron-identified as promising following preliminary beneficial effects in major depressive disorder-represent a relevant strategy.”
Our news reporters obtained a quote from the research from Northumbria University: “This study aimed to assess the efficacy of 8 weeks’ supplementation with 30 mg standardized saffron extract on emotional well-being in healthy adults with subclinical feelings of low mood and anxiety and/or stress and evaluate the acute effect of saffron in response to a lab-based psychosocial stressor. The study adopted a double-blind, randomized, parallel groups design in which 56 healthy male and female individuals (18-54 years) received either a saffron extract or a placebo for 8 weeks. Chronic effects of saffron on subjective anxiety, stress, and depressive feelings were assessed using a questionnaire battery [including Profile of Mood State-2, (POMS)] and acute effects in response to a lab-based psychosocial stressor were measured through psychological and physiological parameters. Urinary crocetin levels were quantified. Participants who received the saffron extract reported reduced depression scores and improved social relationships at the end of the study. Urinary crocetin levels increased significantly with saffron supplementation and were correlated with change in depression scores. The typical stress-induced decrease in heart rate variability (HRV) during exposure to the stressor was attenuated following acute saffron intake.”
According to the news editors, the research concluded: “Saffron extract appears to improve subclinical depressive symptoms in healthy individuals and may contribute to increased resilience against the development of stress-related psychiatric disorders. Clinical trials number: NCT03639831.”
The science of siestas: New research reveals the genetic basis for daytime napping
Massachusetts General Hospital and University of Murcia (Spain), February 13, 2021
How often a person takes daytime naps, if at all, is partly regulated by their genes, according to new research led by investigators at Massachusetts General Hospital (MGH) and published in Nature Communications. In this study, the largest of its kind ever conducted, the MGH team collaborated with colleagues at the University of Murcia in Spain and several other institutions to identify dozens of gene regions that govern the tendency to take naps during the day. They also uncovered preliminary evidence linking napping habits to cardiometabolic health
Napping is somewhat controversial,” says Hassan Saeed Dashti, Ph.D., RD, of the MGH Center for Genomic Medicine, co-lead author of the report with Iyas Daghlas, a medical student at Harvard Medical School (HMS). Dashti notes that some countries where daytime naps have long been part of the culture (such as Spain) now discourage the habit. Meanwhile, some companies in the United States now promote napping as a way to boost productivity. “It was important to try to disentangle the biological pathways that contribute to why we nap,” says Dashti.
Previously, co-senior author Richa Saxena, Ph.D., principal investigator at the Saxena Lab at MGH, and her colleagues used massive databases of genetic and lifestyle information to study other aspects of sleep. Notably, the team has identified genes associated with sleep duration, insomnia, and the tendency to be an early riser or “night owl.” To gain a better understanding of the genetics of napping, Saxena’s team and co-senior author Marta Garaulet, Ph.D., of the Department of Physiology at the University of Murcia, performed a genome-wide association study (GWAS), which involves rapid scanning of complete sets of DNA, or genomes, of a large number of people. The goal of a GWAS is to identify genetic variations that are associated with a specific disease or, in this case, habit.
For this study, the MGH researchers and their colleagues used data from the UK Biobank, which includes genetic information from 452,633 people. All participants were asked whether they nap during the day “never/rarely,” “sometimes” or “usually.” The GWAS identified 123 regions in the human genome that are associated with daytime napping. A subset of participants wore activity monitors called accelerometers, which provide data about daytime sedentary behavior, which can be an indicator of napping. This objective data indicated that the self-reports about napping were accurate. “That gave an extra layer of confidence that what we found is real and not an artifact,” says Dashti.
Several other features of the study bolster its results. For example, the researchers independently replicated their findings in an analysis of the genomes of 541,333 people collected by 23andMe, the consumer genetic-testing company. Also, a significant number of the genes near or at regions identified by the GWAS are already known to play a role in sleep. One example is KSR2, a gene that the MGH team and collaborators had previously found plays a role in sleep regulation.
Digging deeper into the data, the team identified at least three potential mechanisms that promote napping:
“This tells us that daytime napping is biologically driven and not just an environmental or behavioral choice,” says Dashti. Some of these subtypes were linked to cardiometabolic health concerns, such as large waist circumference and elevated blood pressure, though more research on those associations is needed. “Future work may help to develop personalized recommendations for siesta,” says Garaulet.
Furthermore, several gene variants linked to napping were already associated with signaling by a neuropeptide called orexin, which plays a role in wakefulness. “This pathway is known to be involved in rare sleep disorders like narcolepsy, but our findings show that smaller perturbations in the pathway can explain why some people nap more than others,” says Daghlas.
Boston University School of Public Health, February 13, 2021
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet. While consumption of these beverages has been linked to weight gain, type 2diabetes, early menstruation, and poor semen quality, few studies have directly investigated the relationship between sugary drinks and fertility.
Now, a new study led by Boston University School of Public Health (BUSPH) researchers has found that the intake of one or more sugar-sweetened beverages per day—by either partner—is associated with a decreased chance of getting pregnant.
The study was published in Epidemiology.
"We found positive associations between intake of sugar-sweetened beverages and lower fertility, which were consistent after controlling for many other factors, including obesity, caffeine intake, alcohol, smoking, and overall diet quality," says lead author Elizabeth Hatch, professor of epidemiology. "Couples planning a pregnancy might consider limiting their consumption of these beverages, especially because they are also related to other adverse health effects."
About 15 percent of couples in North America experience infertility. Identifying modifiable risk factors for infertility, including diet, could help couples conceive more quickly and reduce the psychological stress and financial hardship related to fertility treatments, which are associated with more than $5 billion in annual US healthcare costs.
Through the Pregnancy Study Online (PRESTO), an ongoing web-based prospective cohort study of North American couples, the researchers surveyed 3,828 women aged 21 to 45 living in the United States or Canada and 1,045 of their male partners. Participants completed a comprehensive baseline survey on medical history, lifestyle factors, and diet, including their intake of sugar-sweetened beverages. Female participants then completed a follow-up questionnaire every two months for up to 12 months or until pregnancy occurred.
Both female and male intake of sugar-sweetened beverages was associated with 20 percent reduced fecundability, the average monthly probability of conception. Females who consumed at least one soda per day had 25 percent lower fecundability; male consumption was associated with 33 percent lower fecundability. Intake of energy drinks was related to even larger reductions in fertility, although the results were based on small numbers of consumers. Little association was found between intake of fruit juices or diet sodas and fertility.
"Given the high levels of sugar-sweetened beverages consumed by reproductive-aged couples in North America, these findings could have important public healthimplications," the authors concluded.
Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.
Salk Institute for Biological Studies, February 16, 2021
The results of a recent study are offering new hope that avoiding memory loss related to aging as well as Alzheimer’s disease could be as simple as eating more cucumbers.
Many older adults resign themselves to memory loss as part of the aging process. However, a study out of the the Salk Institute for Biological Studies has shown that this doesn’t have to be the case. The health benefits of cucumbers are many, and one of them seems to be better memory and even the prevention of Alzheimer’s disease.
Researchers working with mice that normally developed the symptoms of Alzheimer’s (including memory loss) discovered that a daily dose of a flavonol called fisetin prevented these and other related impairments. This improvement occurred despite the continued formation of amyloid plaques, the brain proteins commonly blamed for Alzheimer’s.
The compound fisetin is found in numerous vegetables and fruits but is especially concentrated in strawberries and cucumbers. This flavonol is quite effective in stopping memory loss in mice and holds hope for humans as well.
In the past, the main approach to treating Alzheimer’s symptoms was to target amyloid plaques in the brain. The findings of this study call into question the assumption that these proteins are largely responsible for the effects of Alzheimer’s.
Even in animals with no signs of Alzheimer’s and otherwise normal functioning, fisetin has been shown to improve memory. However, its ability to prevent memory loss associated with Alzheimer’s disease could have profound implications for humans.
Fisetin works by switching on a cellular pathway associated with the process of retrieving memories in the brain. Over a decade ago, other researchers discovered the compound fisetin assists in protecting the neurons of the brain from agingand its associated effects. It was found that this potent compound has both anti-inflammatory and antioxidant effects on brain cells.
The list of health benefits of cucumbers, strawberries and other fruits and vegetables containing fisetin now include brain and memory improvements. By extension, fisetin has properties that can be highly beneficial for those at risk for Alzheimer’s.
In addition to improving memory and potentially protecting against Alzheimer’s, the cucumber fruit has a range of additional nutritional and health benefits. They are low in calories (a cup of cucumbers contains just 16 calories) and assist in hydration (they are comprised of 95 percent water). They also provide flavonoids, triterpenes and lignans which offer anti-inflammatory, antioxidant and cancer-preventing benefits.
The peel and seeds in cucumbers contain beta-carotene for eye health and are the most nutrient-dense portions of the fruit. Cucumber seeds contain calcium and the skin and seeds are also excellent sources of fiber. Other vitamins include potassium, vitamin C, magnesium and manganese.
Jiangxi University of Traditional Chinese Medicine, February 14, 2021
According to news originating from Jiangxi, People’s Republic of China, research stated, “Despite the fact that numerous clinical studies have evaluated the positive effects of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and on the body mass index (BMI), more evidence is needed to certify that DHEA is a BMI-reducing agent in the elderly. This meta-analysis aims to clarify the various incompatible results and investigate the impact of DHEA supplementation on serum testosterone levels and lean body mass in elderly women.”
Our news journalists obtained a quote from the research from the Jiangxi University of Traditional Chinese Medicine, “Four scientific databases (EMBASE, PubMed/MEDLINE, Scopus and Web of Science) were searched from inception until 20 August 2020 for trials comparing DHEA with placebo. Results were presented as weighted mean differences (WMDs) and 95 % confidence intervals (CIs) based on the random effects model (DerSimonian-Laird approach). Nine arms with 793 subjects reported testosterone as an outcome measure. The overall results demonstrated that testosterone levels increased significantly after DHEA administration in elderly women (WMD: 17.52 ng/dL, 95 % CI: 6.61, 28.43, P = 0.002). In addition, DHEA administration significantly decreased the BMI (WMD:-0.39 kg/m(2), I-2 = 0.0 %).”
According to the news editors, the research concluded: “The results of the current meta-analysis support the use of DHEA supplementation for increasing testosterone concentrations in elderly women.”
This research has been peer-reviewed.
Harvard School of Public Health, February 15, 2021
Combining healthy lifestyle interventions reduces heart disease through beneficial effects on different lipoproteins and associated cholesterols, according to a study published February 9 in eLife.
Having a healthy lifestyle has long been associated with a lower risk of developing heart disease. The new study provides more detailed information on how healthy lifestyles improve cholesterol, and suggests that combining cholesterol-lowering medications and lifestyle interventions may yield the greatest benefits to heart health.
Cholesterol-lowering medications such as statins help reduce heart risks by lowering levels of low-density lipoprotein (LDL) cholesterol, the so-called "bad" cholesterol. Healthy lifestyle interventions, including exercising regularly, having a healthy diet, lowering alcohol consumption and maintaining a healthy weight, have also been shown to lower LDL as well as increase "healthy" high-density lipoprotein (HDL) cholesterol.
"Until now, no studies have compared the lipid-lowering effects of cholesterol-lowering medications and healthy lifestyle interventions side by side," says lead author Jiahui Si, Postdoctoral Research Fellow in the Department of Epidemiology at Harvard T.H. Chan School of Public Health, Boston, Massachusetts, US.
To address this gap, Si and colleagues used a technique called targeted nuclear magnetic resonance spectroscopy to measure 61 different lipid markers in blood samples from 4,681 participants in the China Kadoorie Biobank, including cases of stroke, coronary heart disease and healthy individuals. They studied lipid markers in the blood of participants who had multiple healthy lifestyle habits and compared them to those of participants with less healthy habits. They found 50 lipid markers associated with a healthy lifestyle.
When the team looked at a subset of 927 individuals who had coronary heart disease in the next 10 years and 1,513 healthy individuals, they found 35 lipid markers that showed statistically significant mediation effects in the pathway from healthy lifestyles to the reduction of heart disease. Together, the combined beneficial effects of the lipid changes associated with healthy lifestyle practices were linked to a 14% reduced risk of heart disease. Specifically, very-low-density lipoprotein (VLDL) and HDL levels in the blood were linked to the heart-protecting benefits of healthy lifestyles.
"Using a genetic scoring technique, we could compare the effect of cholesterol-lowering drugs with that of lifestyle side by side in the study participants," says co-senior author Liming Liang, Associate Professor of Statistical Genetics in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. "Our analysis confirmed that cholesterol-lowering drugs would have the expected effect in lowering LDL cholesterol, but this is much weaker compared to the effect of healthy behaviours on VLDL cholesterol which also increases the risk of heart disease."
Overall, they found that taking cholesterol-lowering medications and engaging in multiple healthy lifestyles would likely help individuals to achieve the greatest heart-protecting benefits because of the complementary effects of the drugs and healthy behaviours.
"Lifestyle interventions and lipid-lowering medications may affect different components of the lipid profile, suggesting they are not redundant strategies but could be combined for improved benefits," concludes co-senior author Jun Lv, Professor at the Department of Epidemiology & Biostatistics at the School of Public Health, Peking University Health Science Center, Beijing, China.
University of Utah, February 16
Question How credible is the evidence behind the association of dietary factors with colorectal cancer (CRC) risk in published meta-analyses of prospective observational studies?
Findings This umbrella review of 45 meta-analyses describing 109 associations found convincing evidence for an association between lower CRC risk and higher intakes of dietary fiber, dietary calcium, and yogurt and lower intakes of alcohol and red meat.
Meaning This study suggests that dietary factors may have a role in the development and prevention of CRC, but more research is needed on specific foods for which the evidence remains suggestive.
Abstract
Importance Several meta-analyses have summarized evidence for the association between dietary factors and the incidence of colorectal cancer (CRC). However, to date, there has been little synthesis of the strength, precision, and quality of this evidence in aggregate.
Objective To grade the evidence from published meta-analyses of prospective observational studies that assessed the association of dietary patterns, specific foods, food groups, beverages (including alcohol), macronutrients, and micronutrients with the incidence of CRC.
Data Sources MEDLINE, Embase, and the Cochrane Library were searched from database inception to September 2019.
Evidence Review Only meta-analyses of prospective observational studies with a cohort study design were eligible. Evidence of association was graded according to established criteria as follows: convincing, highly suggestive, suggestive, weak, or not significant.
Results From 9954 publications, 222 full-text articles (2.2%) were evaluated for eligibility, and 45 meta-analyses (20.3%) that described 109 associations between dietary factors and CRC incidence were selected. Overall, 35 of the 109 associations (32.1%) were nominally statistically significant using random-effects meta-analysis models; 17 associations (15.6%) demonstrated large heterogeneity between studies (I2 > 50%), whereas small-study effects were found for 11 associations (10.1%). Excess significance bias was not detected for any association between diet and CRC. The primary analysis identified 5 (4.6%) convincing, 2 (1.8%) highly suggestive, 10 (9.2%) suggestive, and 18 (16.5%) weak associations between diet and CRC, while there was no evidence for 74 (67.9%) associations. There was convincing evidence of an association of intake of red meat (high vs low) and alcohol (≥4 drinks/d vs 0 or occasional drinks) with the incidence of CRC and an inverse association of higher vs lower intakes of dietary fiber, calcium, and yogurt with CRC risk. The evidence for convincing associations remained robust following sensitivity analyses.
Conclusions and Relevance This umbrella review found convincing evidence of an association between lower CRC risk and higher intakes of dietary fiber, dietary calcium, and yogurt and lower intakes of alcohol and red meat. More research is needed on specific foods for which evidence remains suggestive, including other dairy products, whole grains, processed meat, and specific dietary patterns.
Pizza, burgers and the like: A single high-fat meal can damage metabolism
Deutsches Diabetes-Zentrum (Germany), February 16, 2021
The global proliferation of overweight and obese people and people with type 2 diabetes is often associated with the consumption of saturated fats. Scientists at the German Diabetes Center (Deutsches Diabetes-Zentrum, DDZ) and the Helmholtz Center in Munich (HMGU) have found that even the one-off consumption of a greater amount of palm oil reduces the body's sensitivity to insulin and causes increased fat deposits as well as changes in the energy metabolism of the liver. The results of the study provide information on the earliest changes in the metabolism of the liver that in the long term lead to fatty liver disease in overweight persons as well as in those with type 2 diabetes.
In the current issue of the "Journal of Clinical Investigation", DZD researchers working at the German Diabetes Center, in conjunction with the Helmholtz Center in Munich and colleagues from Portugal, published a scientific investigation conducted on healthy, slim men, who were given at random a flavored palm oil drink or a glass of clear water in a control experiment. The palm oil drink contained a similar amount of saturated fat as two cheeseburgers with bacon and a large portion of French fries or two salami pizzas. The scientists showed that this single high-fat meal sufficed to reduce the insulin action, e.g. cause insulin resistance and increase the fat content of the liver. In addition, changes in the energy balance of the liver were proven. The observed metabolic changes were similar to changes observed in persons with type 2diabetes or non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disease in the industrial nations and associated with obesity, the so-called "metabolic syndrome," and is associated with an increased risk in developing type 2 diabetes. Furthermore, NAFLD in advanced stages can result in severe liver damage.
"The surprise was that a single dosage of palm oil has such a rapid and direct impact on the liver of a healthy person and that the amount of fat administered already triggered insulin resistance", explained Prof. Dr. Michael Roden, scientist, Managing Director and Chairman at the DDZ and the German Center for Diabetes Research (Deutsches Zentrum für Diabetesforschung, DZD). "A special feature of our study is that we monitored the liver metabolism of people with a predominantly non-invasive technology, e.g. by magnetic resonance spectroscopy. This allows us to track the storage of sugar and fat as well as the energy metabolism of the mitochondria (power plants of the cell)." Thanks to the new methods of investigation, the scientists were able to verify that the intake of palm oil affects the metabolic activity of muscles, liver and fatty tissue. The induced insulin resistance leads to an increased new formation of sugar in the liver with a concomitant decreased sugar absorption in the skeletal muscles - a mechanism that makes the glucose level rise in persons afflicted with type 2 diabetes and its pre-stages. In addition, the insulin resistance of the fatty tissue causes an increased release of fats into the blood stream, which in turn continues to foster the insulin resistance. The increased availability of fat leads to an increased workload for the mitochondria, which can in the long term overtax these cellular power plants and contribute to the emergence of a liver disease.
The team of Prof. Roden suspects that healthy people, depending on genetic predisposition, can easily manage this direct impact of fatty food on the metabolism. The long-term consequences for regular eaters of such high-fat meals can be far more problematic, however.
Public Service -- update on Covid actions in New York and DNA collection
Michael (Mike) Kane has worked as a New York City public school teacher for over 13 years and is a steering committee member of NY TEACHERS FOR CHOICE, a grassroots union caucus of educators and parents that is 100% opposed to all medical mandates to maintain employment. Recently TEACHERS FOR CHOICE sued the NYC Department of Education with their attorney Michael Sussman and won a court-ordered stipulation pertaining to in-school COVID testing and privacy rights. Kane has been a proud union member and active supporter of the United Federation of Teachers (UFT) for his entire career. He is a former union delegate, served on union consultation committees, lobbied in Albany on behalf of the union on multiple occasions, and protested with rank-&-file union members against the Bloomberg administration. His website is www.nyteachersforchoice.org
By Prof. Dr. Thomas Aigner
Global Research, February 14, 2021
Letter to the President of the Academy of Sciences and Literature in Mainz,
Dear colleagues,
With greatest astonishment, with deepest concern, even bewilderment, I have taken note of the “7th ad hoc statement” of the National Academy of Sciences Leopoldina of 8.12.2020. In my opinion, this paper is not worthy of an honest, critical-balancing science oriented towards the service and welfare of human beings. I do not have medical expertise. However, as a scientist committed to nothing but the pure truth, I take the liberty of speaking out.
I feel very strongly alarmed by several points:
“External peer review of the RT-PCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results”.
Quote: “This highly questions the scientific validity of the test”. Furthermore, the serious remark: “serious conflicts of interest of the authors are not mentioned” (1).
“the test (is) unsuitable as a specific diagnostic tool to identify the SARS-CoV-2 virus and make inferences about the presence of an infection”.
Is it not obvious that there is an extremely serious problem here, which should actually shake the whole “pandemic”? I cannot understand why neither the Leopoldina nor other academies include this well-founded expert opinion and demand or initiate a further, thorough and scientifically clean clarification.
Incidentally, there are currently several statements by medical practitioners that are diametrically opposed to the Leopoldina paper. For example, the Chairman of the Board of the National Association of Statutory Health Insurance Physicians, Prof. Gassen, expects that the hard lockdown now ordered will fail (3). The infectiologist Prof. Schrappe declares the entire lockdown policy a definite failure (4).
I had hoped that the Academy of Sciences and Literature in Mainz, as an important sister organization of the National Academy of Sciences, would make a critical statement on the Leopoldina statement. Regrettably, this has not happened so far. Are not the academies the guardians of pure science and also of the freedom of the sciences ? Aren’t the venerable academies particularly challenged in a scientific landscape that is increasingly characterized by third-party funding and the massive influence of powerful lobby interests (e.g. the pharmaceutical industry)? Is it really the task of an academy such as the Leopoldina to fuel the scaremongering of the media and politics?
After the governments refer to this, from my point of view disastrous paper of the National Academy of Sciences when imposing a renewed “hard lockdown”, as well as because of the points listed above, I have decided, after careful consideration, to take the certainly unusual step of resigning from the Academy of Sciences in Mainz as an expression of my personal protest.
I cannot reconcile it with my conscience to be a part of this kind of science. I want to serve a science that is committed to fact-based honesty, balanced transparency, and comprehensive humanity.
For the attention of Prof. Dr. Burkhard Hillebrands (Vice President, Mathematical and Natural Sciences Class),
members of the Mathematical and Natural Sciences Class of the Mainz Academy of Sciences,
and Prof. Dr. Gerald Haug (President of the National Academy of Sciences Leopoldina).
Positive PCR tests drop after WHO instructs vendors to lower cycle thresholds. We have been played like a fiddle
Hospitalization rates associated with Covid have dropped from a high of 132,500 Americans on January 6 to 71,500 on February 12. The US had 920,000 staffed hospital beds in 2019, of which 14.4% harbored a Covid case last month, and 7.8% do now.
This tremendous drop was predicted. Every hospitalized patient is tested for Covid, often repeatedly, using PCR tests with high false positive rates. False positives are due in considerable part to exhorbitant cycle thresholds. This refers to the maximum number of doublings that are allowed during the test. The problem caused by excessive cycle thresholds was well described in a NY Times article last August, but has otherwise been ignored by the mass media. Dr. Sin Hang Lee challenged the FDA’s reliance on exhorbitant cycle thresholds in its acceptance of efficacy claims for Pfizer’s Covid-19 vaccine in early December. He and FDA remain engaged in this debate.
The WHO instructed PCR test users and manufacturers on December 14 and again on January 20 that PCR cycle thresholds needed to come down. The December 14 guidance stated WHO’s concern regarding “an elevated risk for false SARS-CoV-2 results” and pointed to “background noise which may lead to a specimen with a high cycle threshold value result being [incorrectly] interpreted as a positive result.”
The first instruction has been superceded by the second, which additionally advises on clinical use of the test: If the “test results do not correspond with the clinical presentation, a new specimen should be taken and retested…” While this implies that the test should only be performed in those with symptoms, and its results should be interpreted with the clinical context in mind, most PCR tests in the US are used very differently: to screen asymptomatics at work, at colleges and universities, to permit border crossings, etc. No caution is applied to the results. One single positive test defines someone as a Covid case. Yet it is well known, and was acknowledged in WHO’s January guidance, that screening in low Covid prevalence situations, such as in the screening of asymptomatics, increases the risk of false positives. And the risk increases as the prevalence of disease drops, such that in situations of low disease prevalence, it is common to find that most positives are actually false positives. For example, see this BMJ chart and then the real-life example in the comment below it.
Everyone in the field knew that the PCR test results were bogus. Even Tony Fauci admitted last July that cycle thresholds above 35 were not measuring virus, and furthermore that virus could not be cultured from samples that required a high number of cycles to show positivity.
But the drumbeat from the Coronavirus Task Force and some academics and others was “Test all, test often”–despite the inordinate numbers of false positives and negatives. Congress repeatedly allocated many billions of dollars for testing (often free for the person being tested) and so testing quickly mushroomed. Nearly two million Covid tests a day were recorded in the US over the last 3 months. Most of these have been PCR tests which, despite their problems, are still considered the most accurate. Most of the remaining tests performed were rapid antigen tests. These tests too suffer from high false positive rates, as the FDA warned last November.
While daily deaths have only dropped about 15% since January 12, there have been dramatic drops during the month in new cases (down 60% from 250,000 new cases/day to 100,000) and, as noted, in hospitalizations (down 46%). Reports claim a total of 475,000 Americans have died from Covid.
However, none of these numbers are reliable. In addition to inaccurate PCR results, a variety of other measures have skewed the reported number of deaths from Covid.
While CDC electronically codes other causes of death, it has chosen to hand code every Covid death, and explains:
o “It takes extra time to code COVID-19 deaths. While 80% of deaths are electronically processed and coded by NCHS within minutes, most deaths from COVID-19 must be coded by a person, which takes an average of 7 days.”
I am waiting for CDC to answer my Freedom of Information Act query, which requested the protocol CDC’s coders use for coding Covid-19 as a cause of death. Why is CDC treating Covid deaths differently from deaths due to other conditions?
CDC changed the way it coded death certificates for a Covid-caused death last March, to include everyone for whom Covid is in any way contributory to the death. By placing different parts of the instructions about coding on different web pages, CDC successfully hid what it was doing. On one page, the guidance states, “If COVID-19 is determined to be a cause of death, it should be reported on the death certificate.” On a different webpage, CDC states: “When COVID-19 is reported as a cause of death on the death certificate, it is coded and counted as a death due to COVID-19.”
CDC has encouraged providers to be generous with Covid designations. And the Covid death definition appears to be a moving target, variable across states. CDC attempts to explain why its mortality numbers do not add up, and includes this excuse: “Other reporting systems use different definitions or methods for counting deaths.” But it is CDC that chose not to issue uniform guidelines.
“We consider COVID-19 deaths to be:
Deaths in which a patient hospitalized for any reason within 14 days of a positive COVID-19 test result dies in the hospital or within the 60 days following discharge.
Deaths in which COVID-19 is listed as a primary or contributing cause of death on a death certificate.”
Weekly mortality surveillance data include a combination of machine coded and manually coded causes of death collected from death certificates. Prior to week 4 (the week ending January 30, 2021), the percentages of deaths due to PIC were higher among manually coded records than more rapidly available machine coded records. Improvements have been made to the machine coding process that allow for more COVID-19 related deaths to be machine coded, and going forward, the percentage of PIC deaths among machine coded and manually coded data are expected to be more similar. The data presented are preliminary and expected to change as more data are received and processed, but the amount of change in the percentage of deaths due to PIC should be lower going forward. Weeks for which the largest changes in the percentage of deaths due to PIC may occur are highlighted in gray in the figure below and should be interpreted with caution.
By accepting excessive cycle thresholds for Covid PCR tests, CDC considerably expanded the numbers of Covid-positive cases and hospitalizations, as well as deaths.
I do not mean to imply that the tests, whose manufacturers may have recently reduced their cycle thresholds, are now accurate. Over 200 different PCR tests have been “authorized” under emergency rules by the FDA, which so far has not standardized or formally approved them. The public is in the dark as to whether and how each individual test may have changed in response to WHO’s instruction, and we remain uninformed about the accuracy of each test. In fact, it has been established by the American College of Pathology that PCR test results are not reproducible.
Today, the media are telling us to rejoice. Maryland has just gotten its percentage of positive Covid tests below 5%, when a month ago the rate was 8.76%. In my state of Maine, a reduction in the pecentage of test results that are positive has turned all counties ‘green,’ allowing schools to be open.
————–
Things are worse, things are better. Wear no mask–no, wear a mask–hey, wear two masks. New variants with even more infectivity are coming! But they are no more lethal, and SARS-CoV-2 is quite infectious already, so will the new strains make an appreciable difference?
It seems that despite having recovered from Covid, we can be reinfected with the new viral strains. But how common is that? Does it simply mean you can have a positive PCR test, but be otherwise asymptomatic?
I found only a single case report of a person becoming severely ill from a new strain after having recovered from original Covid.
Our families are being torn up. Our small businesses are going bankrupt. Our countries, and probably we ourselves, are being scooped up by the banks, as borrowing on an unheard-of scale persists at a dizzying pace.
Who will pay these debts? What will be the price? Can you see that the crashing of our economies is intentional, buttressed by lie after lie?
We are being lied into the abyss. Our so-called leaders are tossing us and especially our children and grandchildren over a cliff. They threw away our Constitution long ago. Now, they have stolen and sold our future.
Please calm down. Turn off all the “news” and ponder what has been happening. We can fix this mess, once enough of us understand it. Give it the time and focus it deserves. Our leaders won’t save us. Only WE can.